4
Changes in Ownership
ARROWHEAD PHARMACEUTICALS, INC. Filed Acc 0001628280-24-000744
COO and General Counsel sold 33,190 shares at an average $34.36 ($1,140,362)
- COO and General Counsel acquired 85,000 shares (grant or award)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| O'Brien Patrick COO and General Counsel | 2024-01-03 | Sale 10b5-1 | −3,849 | $31.83 | $122,514 | 408,726 | D: show line 1 in the form |
| O'Brien Patrick COO and General Counsel | 2024-01-03 | Sale 10b5-1 | −2,800 | $32.52 | $91,056 | 405,926 | D: show line 2 in the form |
| O'Brien Patrick COO and General Counsel | 2024-01-03 | Sale 10b5-1 | −400 | $33.41 | $13,364 | 405,526 | D: show line 3 in the form |
| O'Brien Patrick COO and General Counsel | 2024-01-03 | Sale 10b5-1 | −1,700 | $32.65 | $55,505 | 403,826 | D: show line 4 in the form |
| O'Brien Patrick COO and General Counsel | 2024-01-04 | Sale 10b5-1 | −1,600 | $32.63 | $52,208 | 402,226 | D: show line 5 in the form |
| O'Brien Patrick COO and General Counsel | 2024-01-04 | Grant or award 10b5-1 | +85,000 | 487,226 | D: show line 6 in the form | ||
| O'Brien Patrick COO and General Counsel | 2024-01-05 | Sale 10b5-1 | −1,900 | $33.99 | $64,581 | 485,326 | D: show line 7 in the form |
| O'Brien Patrick COO and General Counsel | 2024-01-05 | Sale 10b5-1 | −8,200 | $34.99 | $286,918 | 477,126 | D: show line 8 in the form |
| O'Brien Patrick COO and General Counsel | 2024-01-05 | Sale 10b5-1 | −12,741 | $35.65 | $454,217 | 464,385 | D: show line 9 in the form |
| Open-market sales · 33,190 sh · avg $34.36 · $1,140,362 | |||||||
Loading xslF345X05/wk-form4_1704502718.xml…